Joseph S. Zakrzewski

Insider Reports History

Location
New Hope, PA
Signature
/s/ Lucy Day, Attorney-in-Fact for Joseph S. Zakrzewski
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph S. Zakrzewski:

Company Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Director Common Stock 405,880 $544,285 $1.34 10 Apr 2025 Indirect
Cyteir Therapeutics, Inc. Director Common Stock 227,439 $384,372 $1.69 06 Feb 2024 Direct
Cyteir Therapeutics, Inc. Director Common Stock 149,051 $251,896 $1.69 06 Feb 2024 Indirect
AMARIN CORP PLC\UK Director Ordinary Shares 196,547 $214,236 $1.09 15 Dec 2021 Direct
AN2 Therapeutics, Inc. Director Common Stock 145,538 $195,166 $1.34 10 Apr 2025 Direct
AMARIN CORP PLC\UK Director Stock Option (Right to Buy) 45,953 $49,629 $1.08 14 Jun 2021 Direct
SANGAMO THERAPEUTICS, INC Director Common Stock 60,700 $23,193 $0.3821 25 Feb 2022 Direct
AMARIN CORP PLC\UK Director Restricted Stock Units 36,000 14 Jun 2021 Direct
SANGAMO THERAPEUTICS, INC Director Stock Option (Right to Buy) 25,000 25 Feb 2022 Direct
AN2 Therapeutics, Inc. Director Stock Option (Right to Buy) 19,111 22 May 2025 Direct
ACCELERON PHARMA INC Director Common Stock 0 $175.00 19 Nov 2021 Direct
ACCELERON PHARMA INC Director Option to Purchase Common Stock 0 19 Nov 2021 Direct
Cyteir Therapeutics, Inc. Director Stock Option (Right to Buy) 0 06 Feb 2024 Direct

Insider Reports Filed by Joseph S. Zakrzewski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ANTX AN2 Therapeutics, Inc. 22 May 2025 1 $0 4 Director 23 May 2025, 16:58
ANTX AN2 Therapeutics, Inc. 10 Apr 2025 1 $0 4 Director 11 Apr 2025, 17:08
ANTX AN2 Therapeutics, Inc. 19 Dec 2024 1 $0 4 Director 23 Dec 2024, 18:33
ANTX AN2 Therapeutics, Inc. 27 Nov 2024 1 +$2,800 4 Director 27 Nov 2024, 16:16
ANTX AN2 Therapeutics, Inc. 18 Nov 2024 2 +$25,046 4 Director 20 Nov 2024, 16:11
ANTX AN2 Therapeutics, Inc. 19 Jun 2024 1 $0 4 Director 21 Jun 2024, 18:12
/report/000120919124002992-zakrzewski-joseph-s-2024-02-06 Cyteir Therapeutics, Inc. 06 Feb 2024 2 +$23,914 4 Director 08 Feb 2024, 16:11
ANTX AN2 Therapeutics, Inc. 18 Jan 2024 1 -$1,911,410 4 Director 19 Jan 2024, 19:32
ANTX AN2 Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 20:57
/report/000120919123007560-zakrzewski-joseph-s-2023-02-03 Cyteir Therapeutics, Inc. 03 Feb 2023 1 $0 4 Director 07 Feb 2023, 15:48
/report/000120919122060431-zakrzewski-joseph-s-2022-12-07-restatement Cyteir Therapeutics, Inc. 07 Dec 2022 0 $0 4/A Director 08 Dec 2022, 20:17
ANTX AN2 Therapeutics, Inc. 12 May 2022 1 $0 4 Director 16 May 2022, 21:11
/report/000120919122029135-zakrzewski-joseph-s-2022-05-12 Cyteir Therapeutics, Inc. 12 May 2022 1 +$1,196 4 Director 16 May 2022, 16:24
/report/000120919122028574-zakrzewski-joseph-s-2022-05-10 Cyteir Therapeutics, Inc. 10 May 2022 2 +$95,077 4 Director 12 May 2022, 16:35
ANTX AN2 Therapeutics, Inc. 29 Mar 2022 2 $0 4 Director 31 Mar 2022, 20:15
ANTX AN2 Therapeutics, Inc. 24 Mar 2022 0 $0 3 Director 24 Mar 2022, 21:26
SGMO SANGAMO THERAPEUTICS, INC 25 Feb 2022 2 $0 4 Director 01 Mar 2022, 16:15
/report/000089924322007653-zakrzewski-joseph-s-2022-02-22 Cyteir Therapeutics, Inc. 22 Feb 2022 1 $0 4 Director 24 Feb 2022, 16:03
/report/000089924321049973-zakrzewski-joseph-s-2021-12-23 Cyteir Therapeutics, Inc. 23 Dec 2021 4 +$10,896 4 Director 28 Dec 2021, 17:24
/report/000089924321049198-zakrzewski-joseph-s-2021-12-17 Cyteir Therapeutics, Inc. 17 Dec 2021 1 +$1,976 4 Director 21 Dec 2021, 17:06
/report/000089924321048432-zakrzewski-joseph-s-2021-12-15 Cyteir Therapeutics, Inc. 15 Dec 2021 2 +$39,844 4 Director 15 Dec 2021, 19:09
AMRN AMARIN CORP PLC\UK 14 Dec 2021 2 +$38,999 4 Director 16 Dec 2021, 19:01
/report/000110465921142280-zakrzewski-joseph-s-2021-11-19 ACCELERON PHARMA INC 19 Nov 2021 8 $0 4 Director 22 Nov 2021, 08:12
/report/000089924321025827-zakrzewski-joseph-s-2021-06-22 Cyteir Therapeutics, Inc. 22 Jun 2021 2 $0 4 Director 24 Jun 2021, 20:54
/report/000089924321024598-zakrzewski-joseph-s-2021-06-17 Cyteir Therapeutics, Inc. 17 Jun 2021 0 $0 3 Director 17 Jun 2021, 21:43
AMRN AMARIN CORP PLC\UK 14 Jun 2021 2 $0 4 Director 16 Jun 2021, 20:07